Neoplasms News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Patients With Myeloproliferative Neoplasms May Have Increased Thrombosis Risk - Curetoday.com



Patients With Myeloproliferative Neoplasms May Have Increased Thrombosis Risk 
Curetoday.com
For years, many health care professionals noticed that patients with myeloproliferative neoplasms (MPNs) tend to experience thrombosis more than the average person. Now, a recent population-based study conducted in Sweden confirmed their suspicions. BY ...

and more » 


Clonal Expansion and Aging Fuel the Development of Neoplasms, Say Experts at ASH - AJMC.com Managed Markets Network



Clonal Expansion and Aging Fuel the Development of Neoplasms, Say Experts at ASH 
AJMC.com Managed Markets Network
Vassiliou explained that while some cancers, such as breast cancer, have a large number of mutagens, acute myeloid neoplasms have just 2 known signatures. Accumulation of mutations in 1 of 6 genes leads to clonal hematopoiesis; accumulation of ...

 


Solute carrier transporters: potential targets for digestive system neoplasms - Dove Medical Press



Solute carrier transporters: potential targets for digestive system neoplasms 
Dove Medical Press
Abstract: Digestive system neoplasms are the leading causes of cancer-related death all over the world. Solute carrier (SLC) superfamily is composed of a series of transporters that are ubiquitously expressed in organs and tissues of digestive systems ...

 


Uterine Cancer Market Spotlight 2017-2027: Key Pipeline Drugs, Clinical Trials, Patent Information, Disease ... - Business Wire (press release)



Uterine Cancer Market Spotlight 2017-2027: Key Pipeline Drugs, Clinical Trials, Patent Information, Disease ... 
Business Wire (press release)
The clinical trials distribution across Phases I-IV indicates that the majority of trials for uterine neoplasms have been in early and mid-phases of development, with 96.4% of trials in Phase I-II and only 3.6% in Phase III-IV. The US has a substantial ...

and more » 


Analysis shows 'no clear signal' linking fedratinib to Wernicke's encephalopathy in myeloproliferative neoplasms - Healio



Analysis shows 'no clear signal' linking fedratinib to Wernicke's encephalopathy in myeloproliferative neoplasms 
Healio
ATLANTA ? Incidence of Wernicke's encephalopathy appeared quite low among patients with myeloproliferative neoplasms treated with fedratinib, according to study results presented at ASH Annual Meeting and Exposition. An analysis of nine trials that ...

 


FDA expands clearance of ipsogen JAK2 assay for? - Healio - Healio



Technology Networks
 
FDA expands clearance of ipsogen JAK2 assay for? - Healio 
Healio
The FDA expanded clearance of the ipsogen JAK2 RCQ PCR Kit for supplemental use in the diagnosis of all myeloproliferative neoplasms, according to a company press release. The ipsogen JAK2 RGQ PCR Kit (Qiagen) ? reviewed under a 510(k) pathway ? is a ...
QIAGEN Receives FDA Clearance for JAK2 Diagnostic Test Technology Networks
First JAK2 Test for MPNs Gets FDA Clearance - Rare Disease Report Rare Disease Report

all 3 news articles » 


NFL players with long, short careers have similar death risk: study - Reuters



Reuters
 
NFL players with long, short careers have similar death risk: study 
Reuters
(Reuters) - A study on the health of football players released on Thursday found career participation in the NFL was not associated with a statistically significant increase in death rates when compared with other players who spent less time in the ...

and more » 


Orano Med and RadioMedix announce dosing of first patients in ... - GlobeNewswire (press release)



Orano Med and RadioMedix announce dosing of first patients in ... 
GlobeNewswire (press release)
COURBEVOIE, France and HOUSTON, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Orano Med (formerly AREVA Med) and RadioMedix announced today the dosing of the first three patients in the AlphaMedix? Phase 1 clinical trial. The objective of this Phase 1 is to ...
Orano Med and RadioMedix announce dosing of first patients in AlphaMedix? Phase 1 clinical trial P&T Community

all 1 news articles » 


San Diego County sees first home sale over $20 million in more than a decade - Los Angeles Times



Los Angeles Times
 
San Diego County sees first home sale over $20 million in more than a decade 
Los Angeles Times
The sale is San Diego County's first residential transaction of $20 million or more since 2007, according to real estate agents with knowledge of the area. Advertisement. The buyers are John Hood, chief executive of San Diego-based Impact Biomedicines ...

and more » 


Myeloproliferative Neoplasms Treatment Market - Global Industry ... - Coherent News (press release) (blog)



Coherent News (press release) (blog)
 
Myeloproliferative Neoplasms Treatment Market - Global Industry ... 
Coherent News (press release) (blog)
Myeloproliferative Neoplasms (MPNs) are a group of rare disease, in which the bone marrow produces excess blood cells. It can be white blood cells, red blood.

and more »